Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Failure of 17-hydroxyprogesterone to reduce neonatal morbidity or prolong triplet pregnancy: a double-blind, randomized clinical trial.

Combs CA, Garite T, Maurel K, Das A, Porto M; Obstetrix Collaborative Research Network.

Am J Obstet Gynecol. 2010 Sep;203(3):248.e1-9. doi: 10.1016/j.ajog.2010.06.016. Erratum in: Am J Obstet Gynecol. 2011 Feb;204(2):166.

PMID:
20816146
2.

17-hydroxyprogesterone caproate for twin pregnancy: a double-blind, randomized clinical trial.

Combs CA, Garite T, Maurel K, Das A, Porto M; Obstetrix Collaborative Research Network.

Am J Obstet Gynecol. 2011 Mar;204(3):221.e1-8. doi: 10.1016/j.ajog.2010.12.042.

PMID:
21376161
3.

17 hydroxyprogesterone for the prevention of preterm delivery.

Meis PJ; Society for Maternal-Fetal Medicine.

Obstet Gynecol. 2005 May;105(5 Pt 1):1128-35. Review.

PMID:
15863556
4.

Fetomaternal outcome in triplet pregnancy.

Mazhar SB, Rahim F, Furukh T.

J Coll Physicians Surg Pak. 2008 Apr;18(4):217-21. doi: 04.2008/JCPSP.217221.

PMID:
18474154
5.

Maternal and neonatal outcome of 100 consecutive triplet pregnancies.

Devine PC, Malone FD, Athanassiou A, Harvey-Wilkes K, D'Alton ME.

Am J Perinatol. 2001 Jun;18(4):225-35.

PMID:
11444367
6.

Triplet pregnancy: changes in morbidity and mortality.

Creinin M, Katz M, Laros R.

J Perinatol. 1991 Sep;11(3):207-12.

PMID:
1919816
7.

Progesterone for prevention of recurrent preterm birth: impact of gestational age at previous delivery.

Spong CY, Meis PJ, Thom EA, Sibai B, Dombrowski MP, Moawad AH, Hauth JC, Iams JD, Varner MW, Caritis SN, O'Sullivan MJ, Miodovnik M, Leveno KJ, Conway D, Wapner RJ, Carpenter M, Mercer B, Ramin SM, Thorp JM, Peaceman AM, Gabbe S; National Institute of Child Health and Human Development Maternal Fetal Medicine Units Network.

Am J Obstet Gynecol. 2005 Sep;193(3 Pt 2):1127-31.

PMID:
16157124
8.

Triplet gestation: maternal and neonatal implications.

Syrop CH, Varner MW.

Acta Genet Med Gemellol (Roma). 1985;34(1-2):81-8.

PMID:
4050299
9.

17α-hydroxyprogesterone caproate for the prevention of adverse neonatal outcome in multiple pregnancies: a randomized controlled trial.

Lim AC, Schuit E, Bloemenkamp K, Bernardus RE, Duvekot JJ, Erwich JJ, van Eyck J, Groenwold RH, Hasaart TH, Hummel P, Kars MM, Kwee A, van Oirschot CM, van Pampus MG, Papatsonis D, Porath MM, Spaanderman ME, Willekes C, Wilpshaar J, Mol BW, Bruinse HW.

Obstet Gynecol. 2011 Sep;118(3):513-20. doi: 10.1097/AOG.0b013e31822ad6aa.

PMID:
21860279
10.

Impact of prior gestational age at preterm delivery on effectiveness of 17-alpha-hydroxyprogesterone caproate in practice.

González-Quintero VH, de la Torre L, Rhea DJ, Tudela CM, Vazquez-Vera E, Desch C, Istwan NB.

Am J Obstet Gynecol. 2010 Sep;203(3):257.e1-5. doi: 10.1016/j.ajog.2010.06.020. Epub 2010 Aug 1.

PMID:
20678745
11.

Transabdominal cervical cerclage in triplet pregnancies and risk of extreme prematurity and neonatal loss.

Sumners JE, Moore ES, Ramsey CJ, Eggleston MK.

J Obstet Gynaecol. 2011;31(2):111-7. doi: 10.3109/01443615.2010.542512.

PMID:
21281022
12.

The risk for preterm labor in women receiving 17 alpha-hydroxyprogesterone caproate prophylaxis for preterm birth prevention.

Joy S, Rhea DJ, Istwan NB, Desch CN, Stanziano G.

Am J Perinatol. 2010 Apr;27(4):343-8. doi: 10.1055/s-0029-1243306. Epub 2009 Dec 10.

PMID:
20013580
13.

Perinatal and neonatal outcomes in multiple gestations: assisted reproduction versus spontaneous conception.

Fitzsimmons BP, Bebbington MW, Fluker MR.

Am J Obstet Gynecol. 1998 Nov;179(5):1162-7.

PMID:
9822494
14.

Prevention of preterm birth in triplets using 17 alpha-hydroxyprogesterone caproate: a randomized controlled trial.

Caritis SN, Rouse DJ, Peaceman AM, Sciscione A, Momirova V, Spong CY, Iams JD, Wapner RJ, Varner M, Carpenter M, Lo J, Thorp J, Mercer BM, Sorokin Y, Harper M, Ramin S, Anderson G; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Maternal-Fetal Medicine Units Network (MFMU).

Obstet Gynecol. 2009 Feb;113(2 Pt 1):285-92. doi: 10.1097/AOG.0b013e318193c677.

15.

Perinatal outcome in triplet versus twin gestations.

Sassoon DA, Castro LC, Davis JL, Hobel CJ.

Obstet Gynecol. 1990 May;75(5):817-20.

PMID:
2325964
16.

Neonatal morbidity and mortality associated with triplet pregnancy.

Kaufman GE, Malone FD, Harvey-Wilkes KB, Chelmow D, Penzias AS, D'Alton ME.

Obstet Gynecol. 1998 Mar;91(3):342-8.

PMID:
9491857
17.

Maternal neonatal outcome in quadruplet and quintuplet versus triplet gestations.

Skrablin S, Kuvacić I, Pavicić D, Kalafatić D, Goluza T.

Eur J Obstet Gynecol Reprod Biol. 2000 Feb;88(2):147-52.

PMID:
10690673
18.

Outcome of twin, triplet, and quadruplet in vitro fertilization pregnancies: the Norfolk experience.

Seoud MA, Toner JP, Kruithoff C, Muasher SJ.

Fertil Steril. 1992 Apr;57(4):825-34.

PMID:
1555695
19.

Embryo reduction versus expectant management in triplet pregnancies.

Antsaklis A, Souka AP, Daskalakis G, Papantoniou N, Koutra P, Kavalakis Y, Mesogitis S.

J Matern Fetal Neonatal Med. 2004 Oct;16(4):219-22.

PMID:
15590450
20.

Antepartum management and neonatal outcome of triplet pregnancies.

Zanconato G, Poggi S, Ruffo R, Gazzoni A, Padovani EM, Franchi M.

Arch Gynecol Obstet. 2005 Apr;271(4):320-4. Epub 2004 May 28.

PMID:
15168131

Supplemental Content

Support Center